Cemtrex New (CTEI) 0.5290 $CTEI
Cemtrex Receives New Orders Totaling Over $5 Million for Products in Medical Devices, Wearable Electronics, and Industrial Markets
PR Newswire - Tue Jan 20, 7:40AM CST
Cemtrex, Inc. (OTC: CTEI) today announced that the company has received new orders in excess of $5,000,000 in its electronics manufacturing business.
Cemtrex's Chairman & CEO, Saagar Govil, interviewed by The Wall Street Analyzer
PR Newswire - Tue Jan 06, 11:34AM CST
Cemtrex (OTCBB: CTEI) announced today its Chairman & CEO, Saagar Govil, was recently interviewed by The Wall Street Analyzer. Cemtrex recently filed its annual report and finished the year with record sales and net income of $47,653,114 and $2,668,886 respectively. Some highlights from the interview include:
Seeking Alpha: Profitable with Growing Sales, Cemtrex Can Shed Its Microcap Suit
Business Wire - Wed Dec 17, 1:34PM CST
Cemtrex Inc. (OTC:CTEI) was recently highlighted in an article by Payal Gupta of Seeking Alpha. The following are highlights from the recent feature:
MFRI: 6.79 (+0.36)
Key Growth Opportunities:KSA InterviewsDelmar Pharmaceutical,Critical Control Solutions Corp andCemtrex, Inc.
Marketwired - Wed Dec 17, 12:00PM CST
Delmar Pharmaceutical's (OTCQX: DMPI) CEO Jeff Bacha took time to update listeners on the company's lead compound, VAL-083 and it's clinical applications. He talked about how VAL-083 is able to penetrate the elusive blood brain barrier and therefore has potential in treating Glioblastoma in patients that have failed first and second-line therapy. He added that this molecule is also approved in China for the treatment of lung cancer so Delmar has also been generating new preclinical data to reposition the product. Mr. Bacha elaborated on the company's key goals for the next 12 months, the main one being to complete dose escalation and advance into a registration directed trial, which will position them to file for an approval with the FDA regarding refractory Glioblastoma.
CCZ.TO: 0.30 (-0.01)
Profitable With Growing Sales, Cemtrex Can Shed Its Microcap Suit
Payal Gupta - at Seeking Alpha - Mon Dec 15, 2:52PM CST
Saagar Govil is honored as "40 Under Forty" by Stony Brook University
Business Wire - Wed Dec 03, 2:05PM CST
Cemtrex Inc. (OTC:CTEI) -- Saagar Govil, Chairman and CEO of Cemtrex Inc was honored with Top 40 Under Forty Award by Stony Brook University Alumni Association. Stony Brook honored its top 40 alumni under forty years of age who are the brightest, most innovative and entrepreneurial-spirited graduates. These individuals have demonstrated achievements in business, research, technology, the arts, leadership, entrepreneurial or philanthropic endeavors and exemplify the spirit of Stony Brook, including commitment, passion, leadership and the pursuit of excellence.
Cemtrex Announces 2014 Annual Results: Sales Increase by 249%
PR Newswire - Tue Nov 18, 7:30AM CST
Cemtrex Inc. (OTC: CTEI) today announced its fiscal year 2014 consolidated results of operations for the 12 months ended September 30, 2014.
Cemtrex Receives $3 Million in New Orders
PR Newswire - Tue Oct 28, 7:35AM CDT
Cemtrex, Inc. (www.cemtrex.com) today announced that the company has received new orders in excess of $3 million across its two business divisions: Environmental Technologies and Electronics Manufacturing. Deliveries of the ordered products are expected to begin in the fiscal first quarter of 2015 and finishing by the fourth quarter of fiscal 2015.
Cemtrex Sees Increased Activity in its CEMS Business
PR Newswire - Thu Oct 16, 7:40AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that it is experiencing greater proposal activity in its Continuous Emission Monitoring Systems (CEMS) business.
Griffin Filters Sees Strengthening Demand Due to Growth in Frac Sand Market
PR Newswire - Wed Oct 01, 7:40AM CDT
Griffin Filters, a subsidiary of Cemtrex Inc., announced today that they have seen a growing demand for industrial air filtration directly attributable to the oil and gas boom currently taking place in the United States due to hydraulic fracturing technologies.
Cemtrex Chairman and CEO Issues Interim Annual Letter to Shareholders
PR Newswire - Thu Sep 18, 7:30AM CDT
Cemtrex Inc. announced today that Saagar Govil, Chairman and CEO, has issued the following letter to the company's shareholders:
Cemtrex and MODCON to Present at Upcoming 4th Opportunity Crudes Conference September 15 in Houston
PR Newswire - Thu Sep 04, 7:30AM CDT
Cemtrex Inc.(OTCBB: CTEI) announced today that the company will be a featured presenter at the 4th Opportunity Crudes Conference on Monday, September 15, 2014 in Westin Oaks Hotel, Houston, TX.
Cemtrex Reports Highly Successful Q3 2014, with Dramatically Increased Revenue and Net Income
PR Newswire - Wed Jul 30, 7:45AM CDT
Cemtrex, Inc. (OTC: CTEI) (www.cemtrex.com) today announced its third quarter consolidated results of operations for the nine months ended June 30, 2014.
Cemtrex Receives New Orders Totaling Over $7 Million
PR Newswire - Thu Jul 17, 7:30AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that the company has recently received new orders in excess of $7,000,000 across its business divisions: Environmental monitoring and systems & Electronic manufacturing services.
Cemtrex to Expand from Air Filtration to Wastewater Treatment and Bioenergy
PR Newswire - Thu Jun 26, 9:39AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced its expansion into wastewater treatment and bioenergy:
Cemtrex Enters into Letter of Intent to Acquire a Leading Environmental Technology Company
PR Newswire - Mon Jun 23, 7:30AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that the company has entered into a Letter of Intent to purchase all the assets of a foreign, wastewater treatment and bio-energy plant technology company. The acquiree had annual sales of approximately $14 million in 2013. Due to a confidentiality agreement in place the company's name and further details were not disclosed.
Cemtrex Reports Highly Successful Q1 2014, with Surging Sales Driving More than 300% Growth
PR Newswire - Wed Feb 19, 7:40AM CST
Cemtrex, Inc. (OTC: CTEI) (www.cemtrex.com) today announced its first quarter consolidated results of operations for the three months ended December 31, 2013.
TXN: 57.97 (+0.53)
Cemtrex Receives New Orders Totaling Over $5 Million for Products in Medical Devices, Wearable Electronics, and Industrial Markets
PR Newswire - Tue Jan 20, 7:40AM CST
Cemtrex, Inc. (OTC: CTEI) today announced that the company has received new orders in excess of $5,000,000 in its electronics manufacturing business.
Cemtrex's Chairman & CEO, Saagar Govil, interviewed by The Wall Street Analyzer
PR Newswire - Tue Jan 06, 11:34AM CST
Cemtrex (OTCBB: CTEI) announced today its Chairman & CEO, Saagar Govil, was recently interviewed by The Wall Street Analyzer. Cemtrex recently filed its annual report and finished the year with record sales and net income of $47,653,114 and $2,668,886 respectively. Some highlights from the interview include:
Seeking Alpha: Profitable with Growing Sales, Cemtrex Can Shed Its Microcap Suit
Business Wire - Wed Dec 17, 1:34PM CST
Cemtrex Inc. (OTC:CTEI) was recently highlighted in an article by Payal Gupta of Seeking Alpha. The following are highlights from the recent feature:
MFRI: 6.79 (+0.36)
Key Growth Opportunities:KSA InterviewsDelmar Pharmaceutical,Critical Control Solutions Corp andCemtrex, Inc.
Marketwired - Wed Dec 17, 12:00PM CST
Delmar Pharmaceutical's (OTCQX: DMPI) CEO Jeff Bacha took time to update listeners on the company's lead compound, VAL-083 and it's clinical applications. He talked about how VAL-083 is able to penetrate the elusive blood brain barrier and therefore has potential in treating Glioblastoma in patients that have failed first and second-line therapy. He added that this molecule is also approved in China for the treatment of lung cancer so Delmar has also been generating new preclinical data to reposition the product. Mr. Bacha elaborated on the company's key goals for the next 12 months, the main one being to complete dose escalation and advance into a registration directed trial, which will position them to file for an approval with the FDA regarding refractory Glioblastoma.
CCZ.TO: 0.30 (-0.01)
Profitable With Growing Sales, Cemtrex Can Shed Its Microcap Suit
Payal Gupta - at Seeking Alpha - Mon Dec 15, 2:52PM CST
Saagar Govil is honored as "40 Under Forty" by Stony Brook University
Business Wire - Wed Dec 03, 2:05PM CST
Cemtrex Inc. (OTC:CTEI) -- Saagar Govil, Chairman and CEO of Cemtrex Inc was honored with Top 40 Under Forty Award by Stony Brook University Alumni Association. Stony Brook honored its top 40 alumni under forty years of age who are the brightest, most innovative and entrepreneurial-spirited graduates. These individuals have demonstrated achievements in business, research, technology, the arts, leadership, entrepreneurial or philanthropic endeavors and exemplify the spirit of Stony Brook, including commitment, passion, leadership and the pursuit of excellence.
Cemtrex Announces 2014 Annual Results: Sales Increase by 249%
PR Newswire - Tue Nov 18, 7:30AM CST
Cemtrex Inc. (OTC: CTEI) today announced its fiscal year 2014 consolidated results of operations for the 12 months ended September 30, 2014.
Cemtrex Receives $3 Million in New Orders
PR Newswire - Tue Oct 28, 7:35AM CDT
Cemtrex, Inc. (www.cemtrex.com) today announced that the company has received new orders in excess of $3 million across its two business divisions: Environmental Technologies and Electronics Manufacturing. Deliveries of the ordered products are expected to begin in the fiscal first quarter of 2015 and finishing by the fourth quarter of fiscal 2015.
Cemtrex Sees Increased Activity in its CEMS Business
PR Newswire - Thu Oct 16, 7:40AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that it is experiencing greater proposal activity in its Continuous Emission Monitoring Systems (CEMS) business.
Griffin Filters Sees Strengthening Demand Due to Growth in Frac Sand Market
PR Newswire - Wed Oct 01, 7:40AM CDT
Griffin Filters, a subsidiary of Cemtrex Inc., announced today that they have seen a growing demand for industrial air filtration directly attributable to the oil and gas boom currently taking place in the United States due to hydraulic fracturing technologies.
Cemtrex Chairman and CEO Issues Interim Annual Letter to Shareholders
PR Newswire - Thu Sep 18, 7:30AM CDT
Cemtrex Inc. announced today that Saagar Govil, Chairman and CEO, has issued the following letter to the company's shareholders:
Cemtrex and MODCON to Present at Upcoming 4th Opportunity Crudes Conference September 15 in Houston
PR Newswire - Thu Sep 04, 7:30AM CDT
Cemtrex Inc.(OTCBB: CTEI) announced today that the company will be a featured presenter at the 4th Opportunity Crudes Conference on Monday, September 15, 2014 in Westin Oaks Hotel, Houston, TX.
Cemtrex Reports Highly Successful Q3 2014, with Dramatically Increased Revenue and Net Income
PR Newswire - Wed Jul 30, 7:45AM CDT
Cemtrex, Inc. (OTC: CTEI) (www.cemtrex.com) today announced its third quarter consolidated results of operations for the nine months ended June 30, 2014.
Cemtrex Receives New Orders Totaling Over $7 Million
PR Newswire - Thu Jul 17, 7:30AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that the company has recently received new orders in excess of $7,000,000 across its business divisions: Environmental monitoring and systems & Electronic manufacturing services.
Cemtrex to Expand from Air Filtration to Wastewater Treatment and Bioenergy
PR Newswire - Thu Jun 26, 9:39AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced its expansion into wastewater treatment and bioenergy:
Cemtrex Enters into Letter of Intent to Acquire a Leading Environmental Technology Company
PR Newswire - Mon Jun 23, 7:30AM CDT
Cemtrex, Inc. (OTC: CTEI) today announced that the company has entered into a Letter of Intent to purchase all the assets of a foreign, wastewater treatment and bio-energy plant technology company. The acquiree had annual sales of approximately $14 million in 2013. Due to a confidentiality agreement in place the company's name and further details were not disclosed.
Cemtrex Reports Highly Successful Q1 2014, with Surging Sales Driving More than 300% Growth
PR Newswire - Wed Feb 19, 7:40AM CST
Cemtrex, Inc. (OTC: CTEI) (www.cemtrex.com) today announced its first quarter consolidated results of operations for the three months ended December 31, 2013.
TXN: 57.97 (+0.53)
